General
Baricitinib improves patient-reported outcomes in RA
 

Baricitinib improves patient-reported outcomes in RA

Shared by:

 
Baricitinib may produce meaningful improvements in patient-reported outcomes in rheumatoid arthritis (RA) patients with previously inadequate responses to biological disease-modifying antirheumatic drugs, according to data from the RA-BEACON trial.
 
specialty.mims.com
 
12 Dec 2016 - General
 
Another good news for those who are suffering from rheumatoid arthritis! However I just wonder what kind of objectives did this new drug baricitinib didn't met and it was mentioned that others cannot tolerate it? I wonder what are the adverse and...
 (Total 81 words)